Results 31 to 40 of about 43,370 (253)

Additional file 6: Figures S1â S7. of The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading

open access: yes, 2017
Supplementary figures with legends. (DOCX 3897 kb)
Tarallo, Roberta   +17 more
openaire   +1 more source

Expression of ERα in podocytes.

open access: yes, 2013
A) Immunocytochemical staining of ERα (red) in cultured murine podocytes with cytoplasmatic and nuclear localization. DAPI was used for nuclear staining (blue), negative control was performed without ERα primary antibody. B) Immunohistochemical detection
Sebastian Kummer (339692)   +13 more
core   +1 more source

ERα localization to lysosomes.

open access: yes, 2014
(A) Growing MCF-7 cells were co-stained with anti-ERα Sp-1 and D-12 antibodies. (B) Growing pc DNA flag ERα -transfected HeLa cells were co-stained with anti-ERα HC-20 and flag antibodies. (C) Western blot analysis of ERα cellular levels in growing MCF-7
Valeria Pesiri (552188)   +3 more
core   +1 more source

Interactions between ERα and DUSP22 / LMW-DSP2 [PDF]

open access: yes, 2007
In the previous study, we demonstrated the involvement of dual specificity phosphatase 22 (DUSP22 / LMW-DSP2) in regulating the LIF/IL-6/STAT3-mediated signaling pathway.
Sekine, Yuichi   +15 more
core   +1 more source

Specificity of ERα deletion in aP2-Cre/ERα females.

open access: yes, 2014
(A) RT-PCR analysis of total RNA from inguinal adipose tissue, brown adipose tissue (BAT), liver, uterus, hypothalamus, kidney and muscle from ERαflox/flox and aP2-Cre/ERαflox/flox mice.
Marko Matic (381848)   +11 more
core   +1 more source

ANALISIS IN SILICO GENISTEIN DAN ANALOGNYA SEBAGAI INHIBITOR KANKER PAYUDARA RESEPTOR ESTROGEN ALFA POSITIF (ERα+)

open access: yesJURNAL FARMASI GALENIKA, 2017
Breast cancer is the highest mortality disease on women in the world and about 60-80% of the cases are ERα+ breast cancer. The discovery of more selective to HERα, safe, and potential new anticancer agent is expected to help the treatment of ERα+ breast cancer.
openaire   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa   +8 more
wiley   +1 more source

Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines

open access: yesBMC Cancer, 2009
Background Estrogen receptor-α (ERα) is essential for mammary gland development and is a major oncogene in breast cancer. Since ERα is not colocalized with the cell proliferation marker Ki-67 in the normal mammary glands and the majority of primary ...
Pan Zhongzong, Zhong Yili, Tan Huining
doaj   +1 more source

Effect of the dominant negative S554fs-ERα on ERα levels of CarB cells.

open access: yes, 2013
(A) Wild type and mutant form of ERα. The S554fs-ERα was generated by random chemical mutagenesis of the ERα hormone binding domain (19). (B) Western blot analysis in equally-loaded protein extracts from parental, control vector-transfected (CarB-V) and ...
Vassilis Zoumpourlis (312715)   +9 more
core   +1 more source

Effects of the Fluid Replacement Method During Online Hemodiafiltration on the Solute Removal Performance and Biocompatibility Using the Asymmetric Cellulose Triacetate Membrane

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Pre‐dilution online hemodiafiltration (Pre‐HDF) is predominantly used in Japan, whereas post‐dilution online HDF (Post‐HDF) is more common in Europe. An asymmetric cellulose triacetate (ATA) membrane may improve biocompatibility.
Kenji Sakurai   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy